LONDON BROKER RATINGS: UBS cuts Diageo; Goldman Sachs cuts NatWest
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More
| Price | 330.00p on 23-01-2026 at 19:35:09 |
|---|---|
| Change | 1.00p 0.3% |
| Buy | 331.50p |
| Sell | 329.50p |
| Last Trade: | Buy 75.00 at 330.50p |
| Day's Volume: | 1,194,458 |
| Last Close: | 330.00p |
| Open: | 321.50p |
| ISIN: | GB00BKRC5K31 |
| Day's Range | 321.50p - 333.00p |
| 52wk Range: | 293.00p - 423.00p |
| Market Capitalisation: | £825.91m |
| VWAP: | 329.18286p |
| Shares in Issue: | 250.28m |
Genuit Group (GEN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 75 | 330.50p | Automatic Execution |
16:28:27 - 23-Jan-26 |
| Buy* | 313 | 330.50p | Automatic Execution |
16:28:27 - 23-Jan-26 |
| Buy* | 188 | 330.50p | Automatic Execution |
16:28:27 - 23-Jan-26 |
| Sell* | 816 | 329.50p | Automatic Execution |
16:28:27 - 23-Jan-26 |
| Sell* | 36 | 330.00p | Automatic Execution |
16:28:27 - 23-Jan-26 |
| Sell* | 203 | 330.00p | Automatic Execution |
16:28:25 - 23-Jan-26 |
| Buy* | 2,200 | 330.38p | Ordinary |
16:27:20 - 23-Jan-26 |
| Buy* | 393 | 330.50p | Automatic Execution |
16:26:30 - 23-Jan-26 |
| Buy* | 500 | 330.00p | Automatic Execution |
16:25:00 - 23-Jan-26 |
| Buy* | 734 | 330.00p | Automatic Execution |
16:25:00 - 23-Jan-26 |
Genuit Group (GEN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 12th Jan 2026 5:41 pm | RNS | Holding(s) in Company |
| 31st Dec 2025 10:00 am | RNS | Total Voting Rights |
| 31st Dec 2025 10:00 am | RNS | Total Voting Rights |
| 23rd Dec 2025 9:08 am | RNS | Holding(s) in Company |
| 23rd Dec 2025 9:08 am | RNS | Holding(s) in Company |
| 23rd Dec 2025 9:06 am | RNS | Holding(s) in Company |
| 23rd Dec 2025 9:06 am | RNS | Holding(s) in Company |
| 16th Dec 2025 2:03 pm | RNS | Holding(s) in Company |
| 16th Dec 2025 2:01 pm | RNS | Holding(s) in Company |
| 12th Dec 2025 3:41 pm | RNS | Director/PDMR Shareholding |